PBMs’ ‘Perverse Incentives’ Still Limiting Generics Access, AAM Report Reiterates
Supply Chain Middlemen Continue To Block Patient Access To Cheaper Generic Drugs
Generic medicines continue to be intentionally left off formulary tiers in favor of more expensive brand medications, according to a new report from the US Association for Accessible Medicines.
